CN105031415A - Traditional Chinese medicine formula for activating insulin to regulate hyperglycemia and its preparation and application method - Google Patents
Traditional Chinese medicine formula for activating insulin to regulate hyperglycemia and its preparation and application method Download PDFInfo
- Publication number
- CN105031415A CN105031415A CN201510433172.2A CN201510433172A CN105031415A CN 105031415 A CN105031415 A CN 105031415A CN 201510433172 A CN201510433172 A CN 201510433172A CN 105031415 A CN105031415 A CN 105031415A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- insulin
- hyperglycemia
- regulate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 85
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 44
- 102000004877 Insulin Human genes 0.000 title claims abstract description 42
- 108090001061 Insulin Proteins 0.000 title claims abstract description 42
- 229940125396 insulin Drugs 0.000 title claims abstract description 42
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 230000003213 activating effect Effects 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 241000756042 Polygonatum Species 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 241001061264 Astragalus Species 0.000 claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 11
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 11
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 11
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 11
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 11
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 11
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 11
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 11
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 11
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 11
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 11
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 11
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 11
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 11
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 11
- 241000893536 Epimedium Species 0.000 claims abstract description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 11
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 240000000249 Morus alba Species 0.000 claims abstract description 11
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 11
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 11
- 241000241413 Propolis Species 0.000 claims abstract description 11
- 241000124033 Salix Species 0.000 claims abstract description 11
- 241000270666 Testudines Species 0.000 claims abstract description 11
- 240000008042 Zea mays Species 0.000 claims abstract description 11
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- 235000018905 epimedium Nutrition 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 229940069949 propolis Drugs 0.000 claims abstract description 11
- 210000004233 talus Anatomy 0.000 claims abstract description 11
- 235000021419 vinegar Nutrition 0.000 claims abstract description 11
- 239000000052 vinegar Substances 0.000 claims abstract description 11
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 10
- 241000522190 Desmodium Species 0.000 claims abstract description 10
- 241000405414 Rehmannia Species 0.000 claims abstract description 10
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 9
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 9
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 7
- 241000972672 Phellodendron Species 0.000 claims abstract description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 6
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 6
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 6
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 4
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 4
- 240000006079 Schisandra chinensis Species 0.000 claims abstract 3
- 244000046146 Pueraria lobata Species 0.000 claims abstract 2
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract 2
- 241000605447 Anemarrhena Species 0.000 claims description 10
- 241000271309 Aquilaria crassna Species 0.000 claims description 10
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 10
- 244000197580 Poria cocos Species 0.000 claims description 10
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 10
- 235000007244 Zea mays Nutrition 0.000 claims description 10
- 229930191283 anemarrhena Natural products 0.000 claims description 10
- 229940089639 cornsilk Drugs 0.000 claims description 10
- 229940010454 licorice Drugs 0.000 claims description 10
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 10
- 239000001231 zea mays silk Substances 0.000 claims description 10
- 241001523383 Achnatherum Species 0.000 claims description 9
- 241000092665 Atractylodes macrocephala Species 0.000 claims description 9
- 244000280244 Luffa acutangula Species 0.000 claims description 9
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims description 9
- 241000219780 Pueraria Species 0.000 claims description 9
- 241000222640 Polyporus Species 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 241000208671 Campanulaceae Species 0.000 claims description 7
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 7
- 240000002624 Mespilus germanica Species 0.000 claims description 6
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 6
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 6
- 244000302512 Momordica charantia Species 0.000 claims description 6
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 6
- 241000287826 Gallus Species 0.000 claims description 5
- 241001520921 Leersia virginica Species 0.000 claims description 5
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 239000010072 ban-zhi-lian Substances 0.000 claims description 4
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- 241000167854 Bourreria succulenta Species 0.000 claims description 3
- 241000703121 Campanula rotundifolia Species 0.000 claims description 3
- 235000019693 cherries Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 235000017276 Salvia Nutrition 0.000 claims description 2
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 2
- 235000004789 Rosa xanthina Nutrition 0.000 claims 1
- 241000220222 Rosaceae Species 0.000 claims 1
- 240000007164 Salvia officinalis Species 0.000 claims 1
- 230000003203 everyday effect Effects 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 abstract description 39
- 210000004369 blood Anatomy 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 13
- 229920002527 Glycogen Polymers 0.000 abstract description 8
- 229940096919 glycogen Drugs 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 7
- 239000008103 glucose Substances 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 241000915604 Scutellaria barbata Species 0.000 abstract description 4
- 238000000354 decomposition reaction Methods 0.000 abstract description 4
- 238000006864 oxidative decomposition reaction Methods 0.000 abstract description 4
- 241000132012 Atractylodes Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 244000104272 Bidens pilosa Species 0.000 abstract 1
- 235000010662 Bidens pilosa Nutrition 0.000 abstract 1
- 241000222684 Grifola Species 0.000 abstract 1
- 240000001910 Momordica cochinchinensis Species 0.000 abstract 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 abstract 1
- 235000018365 Momordica dioica Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241001571466 Potentilla discolor Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 210000003038 endothelium Anatomy 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000006870 function Effects 0.000 description 13
- 241000405911 Rehmannia glutinosa Species 0.000 description 9
- 241000736075 Schisandra Species 0.000 description 8
- 241000544066 Stevia Species 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 235000011449 Rosa Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- 235000000664 Rosa chinensis Nutrition 0.000 description 2
- 240000008254 Rosa chinensis Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000007799 cork Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 241000219138 Luffa Species 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008575 shengdi Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域 technical field
本发明属于调节高血糖技术领域，具体涉及一种激活胰岛素调节高血糖功能的中药方及其制备、应用方法。 The invention belongs to the technical field of hyperglycemia regulation, and in particular relates to a traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia and its preparation and application methods.
背景技术 Background technique
血清中的糖称为血糖，绝大多数情况下都是葡萄糖。体内各组织细胞活动所需的能量大部分来自葡萄糖，所以血糖必须保持一定的水平才能维持体内各器官和组织的需要。正常人在清晨空腹血糖浓度为80～120毫克%。 The sugar in the serum is called blood sugar, and in most cases it is glucose. Most of the energy required for the activities of various tissue cells in the body comes from glucose, so blood sugar must be maintained at a certain level to maintain the needs of various organs and tissues in the body. Normal people have a fasting blood sugar concentration of 80-120 mg% in the morning.
空腹血糖浓度超过130毫克%称为高血糖。如果血糖浓度超过160～180毫克%，就有一部分葡萄糖随尿排出，这就是糖尿。短时间、一次性的高血糖对人体无严重损害。比如在应激状态下或情绪激动、高度紧张时，可出现短暂的高血糖；一次进食大量的糖类，也可出现短暂高血糖；随后，血糖水平逐渐恢复正常。然而长期的高血糖会使全身各个组织器官发生病变，导致急慢性并发症的发生。如失水、电解质紊乱、营养缺乏、抵抗力下降、肾功能受损、神经病变、眼底病变、心脑血管疾病、糖尿病足等，为此，控制高血糖势在必行。 A fasting blood sugar concentration of more than 130 mg% is called hyperglycemia. If the blood sugar concentration exceeds 160-180 mg%, part of the glucose will be excreted with the urine, which is diabetes. Short-term, one-time hyperglycemia has no serious damage to the human body. For example, in a state of stress or emotional agitation or high tension, transient hyperglycemia may occur; eating a large amount of carbohydrates at one time may also cause transient hyperglycemia; then, the blood sugar level gradually returns to normal. However, long-term high blood sugar will cause pathological changes in various tissues and organs of the whole body, leading to the occurrence of acute and chronic complications. Such as dehydration, electrolyte imbalance, nutritional deficiency, decreased resistance, impaired renal function, neuropathy, fundus lesions, cardiovascular and cerebrovascular diseases, diabetic foot, etc. Therefore, it is imperative to control hyperglycemia.
发明内容 Contents of the invention
针对上述的不足，本发明目的之一在于，提供一种配方合理，一方面能促进血糖合成糖元，加速血糖的氧化分解并促进血糖转变成脂肪等非糖物质：另一方面又能抑制肝糖元的分解和非糖物质转化为葡萄糖，使血糖含量降低的激活胰岛素调节高血糖功能的中药方。 In view of the above-mentioned deficiencies, one of the purposes of the present invention is to provide a reasonable formula, which can promote the synthesis of glycogen from blood sugar on the one hand, accelerate the oxidative decomposition of blood sugar and promote the transformation of blood sugar into fat and other non-sugar substances; The decomposition of glycogen and the conversion of non-sugar substances into glucose, which lowers blood sugar levels and activates the function of insulin to regulate hyperglycemia.
本发明目的之二在于，提供一种制备上述激活胰岛素调节高血糖功能的中药方的制备方法。该方法的制备工艺简易，易于实现、能快速高效制备出疗效显著的激活胰岛素调节高血糖功能的中药方。 The second object of the present invention is to provide a method for preparing the above-mentioned traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia. The preparation process of the method is simple, easy to implement, and can quickly and efficiently prepare a traditional Chinese medicine prescription with significant curative effect for activating insulin to regulate hyperglycemia.
本发明目的之三在于，提供一种上述激活胰岛素调节高血糖功能的中药方的应用方法。该方法易于实现和操作简单、方便，疗效显著。 The third object of the present invention is to provide an application method of the traditional Chinese medicine formula for activating insulin to regulate hyperglycemia. The method is easy to realize, simple and convenient to operate, and has remarkable curative effect.
为实现上述目的，本发明所提供的技术方案是：一种激活胰岛素调节高血糖功能的中药方，其由以下质量百分比的原料组成：黄芪0.9～1%、黄精0.8～0.9%、茯苓1～1.1%、炒白术1～1.1%、葛根1.3～1.5%、西洋参2～2.3%、五味子0.7～0.95%、地骨皮2～2.3%、生地0.9～1.1%、熟地1.3～1.5%、柳树芽5～6%、鬼针草4～4.5%、马齿苋2～2.2%、甘草0.2～0.45%、当归0.5～0.7%、人参0.6～1%、沉香0.2～0.4%、柿子树叶5～6%、知母2～2.3%、醋鳖甲2～2.25%、盐黄柏1.3～1.51%、猪苓1.1～1.35%、鸡内金3.3～3.63%、金钱草1～1.3%、丝瓜楼2.4～2.64%、蜂胶4.1～4.35%、苦瓜6.1～6.5%、神曲2～2.3%、麦芽0.7～0.95%、红花1.3～1.5%、翻白草6.1～6.5%、山楂2.2～2.6%、首乌2.3～2.52%、金樱子1～1.23%、丹参2～2.3%、半枝莲2.27～2.6%、甜菊叶1.3～1.51%、玉米须2～2.32%、冬桑叶2.3～2.57%、桔梗4.1～4.33%、玉竹2.3～2.5%、淮山3.4～3.63%、淫羊藿0.5～0.68%、枸杞子4.1～4.33%。 In order to achieve the above object, the technical solution provided by the present invention is: a traditional Chinese medicine prescription for activating the function of insulin to regulate hyperglycemia, which is composed of the following raw materials in mass percentage: Astragalus 0.9-1%, Polygonatum 0.8-0.9%, Poria cocos 1- 1.1%, Stir-fried Atractylodes Rhizoma 1-1.1%, Pueraria 1.3-1.5%, American Ginseng 2-2.3%, Schisandra 0.7-0.95%, Digupi 2-2.3%, Rehmannia 0.9-1.1%, Rehmannia 1.3-1.5%, Willow buds 5～6%, ghost needle grass 4～4.5%, purslane 2～2.2%, licorice 0.2～0.45%, angelica 0.5～0.7%, ginseng 0.6～1%, agarwood 0.2～0.4%, persimmon leaves 5～6 %, Anemarrhena 2～2.3%, Vinegar Turtle 2～2.25%, Salt Phellodendron 1.3～1.51%, Polyporus 1.1～1.35%, Gallinarum 3.3～3.63%, Desmodium 1～1.3%, Loofah 2.4～ 2.64%, Propolis 4.1～4.35%, Bitter Melon 6.1～6.5%, Divine Comedy 2～2.3%, Malt 0.7～0.95%, Safflower 1.3～1.5%, Vermilion 6.1～6.5%, Hawthorn 2.2～2.6%, Shouwu 2.3～2.52%, Rosa 1～1.23%, Salvia 2～2.3%, Banzhilian 2.27～2.6%, Stevia leaves 1.3～1.51%, Corn silk 2～2.32%, Winter mulberry leaves 2.3～2.57%, Campanulaceae 4.1-4.33%, Polygonatum 2.3-2.5%, Yam 3.4-3.63%, Epimedium 0.5-0.68%, Wolfberry 4.1-4.33%.
一种上述激活胰岛素调节高血糖功能的中药方的制备方法，其包括以下步骤： A preparation method of the above-mentioned traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia, which comprises the following steps:
（1）预备以下质量百分比的原料：黄芪0.9～1%、黄精0.8～0.9%、茯苓1～1.1%、炒白术1～1.1%、葛根1.3～1.5%、西洋参2～2.3%、五味子0.7～0.95%、地骨皮2～2.3%、生地0.9～1.1%、熟地1.3～1.5%、柳树芽5～6%、鬼针草4～4.5%、马齿苋2～2.2%、甘草0.2～0.45%、当归0.5～0.7%、人参0.6～1%、沉香0.2～0.4%、柿子树叶5～6%、知母2～2.3%、醋鳖甲2～2.25%、盐黄柏1.3～1.51%、猪苓1.1～1.35%、鸡内金3.3～3.63%、金钱草1～1.3%、丝瓜楼2.4～2.64%、蜂胶4.1～4.35%、苦瓜6.1～6.5%、神曲2～2.3%、麦芽0.7～0.95%、红花1.3～1.5%、翻白草6.1～6.5%、山楂2.2～2.6%、首乌2.3～2.52%、金樱子1～1.23%、丹参2～2.3%、半枝莲2.27～2.6%、甜菊叶1.3～1.51%、玉米须2～2.32%、冬桑叶2.3～2.57%、桔梗4.1～4.33%、玉竹2.3～2.5%、淮山3.4～3.63%、淫羊藿0.5～0.68%、枸杞子4.1～4.33%； (1) Prepare the raw materials with the following mass percentages: Astragalus 0.9-1%, Polygonatum 0.8-0.9%, Poria cocos 1-1.1%, Stir-fried Atractylodes macrocephala 1-1.1%, Pueraria 1.3-1.5%, American ginseng 2-2.3%, Schisandra 0.7- 0.95%, Digupi 2～2.3%, Rehmannia 0.9～1.1%, Rehmannia 1.3～1.5%, Willow bud 5～6%, Ghost needle grass 4～4.5%, Purslane 2～2.2%, Licorice 0.2～0.45 %, angelica 0.5-0.7%, ginseng 0.6-1%, agarwood 0.2-0.4%, persimmon leaves 5-6%, Anemarrhena 2-2.3%, vinegar turtle 2-2.25%, salt Phellodendron 1.3-1.51%, pig Ling 1.1～1.35%, Gallus gallis 3.3～3.63%, Desmodium 1～1.3%, Loofah 2.4～2.64%, Propolis 4.1～4.35%, Bitter melon 6.1～6.5%, Divine Comedy 2～2.3%, Malt 0.7～0.95 %, 1.3-1.5% safflower, 6.1-6.5% white grass, 2.2-2.6% hawthorn, 2.3-2.52% Shouwu, 1-1.23% golden cherry, 2-2.3% salvia miltiorrhiza, 2.27-2.6 barbata %, stevia leaves 1.3-1.51%, corn silk 2-2.32%, winter mulberry leaves 2.3-2.57%, bellflower 4.1-4.33%, polygonatum 2.3-2.5%, yam 3.4-3.63%, epimedium 0.5-0.68% , Lycium barbarum 4.1~4.33%;
（2）将上述原料加入中药粉碎机，待粉碎后，获得激活胰岛素调节高血糖功能的中药方； (2) Put the above-mentioned raw materials into a traditional Chinese medicine pulverizer, and after pulverization, obtain a Chinese medicine prescription that activates the function of insulin to regulate hyperglycemia;
（3）将激活胰岛素调节高血糖功能的中药方进行无菌密封装袋。 (3) Aseptically seal the traditional Chinese medicine prescription that activates the function of insulin to regulate hyperglycemia.
一种上述激活胰岛素调节高血糖功能的中药方的应用方法，将所述激活胰岛素调节高血糖功能的中药方进行温水冲服。每天早晚饮用一次，每次1包，1包4克。 A method for applying the above-mentioned traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia, comprising taking the traditional Chinese medicine prescription for activating insulin and regulating hyperglycemia after mixing it with warm water. Drink once a day in the morning and evening, 1 sachet each time, 4 grams per sachet.
本发明的有益效果为：本发明提供的激活胰岛素调节高血糖功能的中药方的配方合理，使体内激活胰岛B细胞分泌胰岛素，它一方面能促进血糖合成糖元，加速血糖的氧化分解并促进血糖转变成脂肪等非糖物质：另一方面又能抑制肝糖元的分解和非糖物质转化为葡萄糖。通过这两个方面的作用，使血糖含量降低，疗效显著，且口感佳，甘甜不含糖；本发明提供的制备方法的工艺简易，易于实现、能快速高效制备出疗效显著的激活胰岛素调节高血糖功能的中药方；本发明提供的应用方法的步骤简单、操作方便，利于广泛推广应用。 The beneficial effects of the present invention are: the formula of the traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia provided by the present invention is reasonable, so that the pancreatic islet B cells are activated to secrete insulin in the body. On the one hand, it can promote blood sugar to synthesize glycogen, accelerate the oxidative decomposition of blood sugar and promote Blood sugar turns into fat and other non-sugar substances: on the other hand, it can inhibit the decomposition of liver glycogen and the conversion of non-sugar substances into glucose. Through the effects of these two aspects, the blood sugar content is reduced, the curative effect is remarkable, and the taste is good, sweet and sugar-free; the preparation method provided by the invention is simple in process, easy to implement, and can quickly and efficiently prepare the activated insulin-regulated insulin with significant curative effect A traditional Chinese medicine prescription for blood sugar function; the application method provided by the invention has simple steps and convenient operation, and is favorable for wide popularization and application.
下面结合实施例，对本发明作进一步说明。 Below in conjunction with embodiment, the present invention will be further described.
具体实施方式 Detailed ways
实施例1：本实施例提供了一种激活胰岛素调节高血糖功能的中药方，其由以下质量百分比的原料组成：黄芪0.92%、黄精0.85%、茯苓1.06%、炒白术1.06%、葛根1.41%、西洋参2.12%、五味子0.85%、地骨皮2.12%、生地1.06%、熟地1.41%、柳树芽5.64%、鬼针草4.23%、马齿苋2.12%、甘草0.35%、当归0.63%、人参0.85%、沉香0.35%、柿子树叶5.64%、知母2.12%、醋鳖甲2.12%、盐黄柏1.41%、猪苓1.27%、鸡内金3.53%、金钱草1.13%、丝瓜楼2.54%、蜂胶4.23%、苦瓜6.35%、神曲2.12%、麦芽0.85%、红花1.41%、翻白草6.35%、山楂2.47%、首乌2.47%、金樱子1.13%、丹参2.12%、半枝莲2.47%、甜菊叶1.41%、玉米须2.12%、冬桑叶2.47%、桔梗4.23%、玉竹2.47%、淮山3.53%、淫羊藿0.68%、枸杞子4.33%。 Example 1: This example provides a traditional Chinese medicine prescription for activating the function of insulin to regulate hyperglycemia, which is composed of the following raw materials in mass percentage: Astragalus 0.92%, Polygonatum 0.85%, Poria cocos 1.06%, Stir-fried Atractylodes macrocephala 1.06%, Pueraria 1.41% , American ginseng 2.12%, Schisandra 0.85%, Digupi 2.12%, Rehmannia 1.06%, Rehmannia glutinosa 1.41%, Willow bud 5.64%, Ghost needle grass 4.23%, Purslane 2.12%, Licorice 0.35%, Angelica 0.63%, Ginseng 0.85% %, agarwood 0.35%, persimmon leaves 5.64%, anemarrhena 2.12%, vinegar turtle 2.12%, salt cortex 1.41%, polyporus 1.27%, gallinacea 3.53%, money grass 1.13%, loofah 2.54%, propolis 4.23 %, bitter gourd 6.35%, divine comedy 2.12%, malt 0.85%, safflower 1.41%, white grass 6.35%, hawthorn 2.47%, Shouwu 2.47%, golden cherry 1.13%, salvia miltiorrhiza 2.12%, barbata 2.47%, Stevia leaf 1.41%, corn silk 2.12%, winter mulberry leaf 2.47%, bellflower 4.23%, polygonatum 2.47%, yam 3.53%, epimedium 0.68%, medlar 4.33%.
本发明提供的激活胰岛素调节高血糖功能的中药方的配方合理，使体内激活胰岛B细胞分泌胰岛素，它一方面能促进血糖合成糖元，加速血糖的氧化分解并促进血糖转变成脂肪等非糖物质：另一方面又能抑制肝糖元的分解和非糖物质转化为葡萄糖。通过这两个方面的作用，使血糖含量降低，疗效显著。 The formula of the traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia provided by the present invention is reasonable, so that the pancreatic islet B cells are activated to secrete insulin in the body. On the one hand, it can promote the synthesis of glycogen from blood sugar, accelerate the oxidative decomposition of blood sugar and promote the conversion of blood sugar into fat and other non-sugars. Substance: On the other hand, it can inhibit the decomposition of liver glycogen and the conversion of non-sugar substances into glucose. Through the effects of these two aspects, the blood sugar content is lowered, and the curative effect is remarkable.
一种上述激活胰岛素调节高血糖功能的中药方的制备方法，其包括以下步骤： A preparation method of the above-mentioned traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia, which comprises the following steps:
（1）预备以下质量百分比的原料：黄芪0.92%、黄精0.85%、茯苓1.06%、炒白术1.06%、葛根1.41%、西洋参2.12%、五味子0.85%、地骨皮2.12%、生地1.06%、熟地1.41%、柳树芽5.64%、鬼针草4.23%、马齿苋2.12%、甘草0.35%、当归0.63%、人参0.85%、沉香0.35%、柿子树叶5.64%、知母2.12%、醋鳖甲2.12%、盐黄柏1.41%、猪苓1.27%、鸡内金3.53%、金钱草1.13%、丝瓜楼2.54%、蜂胶4.23%、苦瓜6.35%、神曲2.12%、麦芽0.85%、红花1.41%、翻白草6.35%、山楂2.47%、首乌2.47%、金樱子1.13%、丹参2.12%、半枝莲2.47%、甜菊叶1.41%、玉米须2.12%、冬桑叶2.47%、桔梗4.23%、玉竹2.47%、淮山3.53%、淫羊藿0.68%、枸杞子4.33%； (1) Prepare the following raw materials by mass percentage: Astragalus 0.92%, Polygonatum 0.85%, Poria cocos 1.06%, Stir-fried Atractylodes macrocephala 1.06%, Pueraria 1.41%, American ginseng 2.12%, Schisandra 0.85%, Digupi 2.12%, Shengdi 1.06%, Rehmannia glutinosa 1.41%, willow bud 5.64%, ghost needle grass 4.23%, purslane 2.12%, licorice 0.35%, angelica 0.63%, ginseng 0.85%, agarwood 0.35%, persimmon leaves 5.64%, anemarrhena 2.12%, vinegar turtle 2.12% %, Salt Cortex 1.41%, Polyporus 1.27%, Gallinarum 3.53%, Desmodium 1.13%, Loofah 2.54%, Propolis 4.23%, Bitter Gourd 6.35%, Divine Comedy 2.12%, Malt 0.85%, Safflower 1.41%, Turnover White grass 6.35%, Hawthorn 2.47%, Shouwu 2.47%, Rosa chinensis 1.13%, Salvia miltiorrhiza 2.12%, Scutellaria barbata 2.47%, Stevia leaves 1.41%, Corn silk 2.12%, Winter mulberry leaves 2.47%, Campanulaceae 4.23%, Polygonatum 2.47%, Huaishan 3.53%, Epimedium 0.68%, Wolfberry 4.33%;
（2）将上述原料加入中药粉碎机，待粉碎后，获得激活胰岛素调节高血糖功能的中药方。 (2) Add the above-mentioned raw materials into a traditional Chinese medicine pulverizer, and after pulverization, obtain a Chinese medicinal formula that activates the function of insulin to regulate hyperglycemia.
（3）将激活胰岛素调节高血糖功能的中药方进行无菌密封装袋。 (3) Aseptically seal the traditional Chinese medicine prescription that activates the function of insulin to regulate hyperglycemia.
本发明提供的制备方法的工艺简易，易于实现、能快速高效制备出疗效显著的激活胰岛素调节高血糖功能的中药方。 The preparation method provided by the invention has a simple process, is easy to implement, and can quickly and efficiently prepare a traditional Chinese medicine prescription with significant curative effect for activating insulin to regulate hyperglycemia.
一种上述激活胰岛素调节高血糖功能的中药方的应用方法，将所述激活胰岛素调节高血糖功能的中药方进行温水冲服。每天早晚饮用一次，每次1包，1包4克。 A method for applying the above-mentioned traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia, comprising taking the traditional Chinese medicine prescription for activating insulin and regulating hyperglycemia after mixing it with warm water. Drink once a day in the morning and evening, 1 sachet each time, 4 grams per sachet.
本发明提供的应用方法的步骤简单、操作方便，利于广泛推广应用。 The application method provided by the invention has simple steps and convenient operation, and is favorable for wide popularization and application.
实施例2，本实施例提供了一种激活胰岛素调节高血糖功能的中药方及其制备、应用方法，其与实施例1基本相同，区别在于：该激活胰岛素调节高血糖功能的中药方由以下质量百分比的原料组成：黄芪1%、黄精0.8%、茯苓1.1%、炒白术1%、葛根1.3%、西洋参2.3%、五味子0.8%、地骨皮2.3%、生地1%、熟地1.3%、柳树芽5%、鬼针草4.5%、马齿苋2%、甘草0.4%、当归0.7%、人参0.6%、沉香0.4%、柿子树叶6%、知母2%、醋鳖甲2.25%、盐黄柏1.3%、猪苓1.35%、鸡内金3.3%、金钱草1.3%、丝瓜楼2.4%、蜂胶4.35%、苦瓜6.5%、神曲2.3%、麦芽0.95%、红花1.3%、翻白草6.5%、山楂2.6%、首乌2.5%、金樱子1%、丹参2.3%、半枝莲2.27%、甜菊叶1.51%、玉米须2.32%、冬桑叶2.57%、桔梗4.1%、玉竹2.3%、淮山3.63%、淫羊藿0.5%、枸杞子4.1%。 Embodiment 2, this embodiment provides a traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia and its preparation and application method, which is basically the same as Example 1, the difference is that the traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia consists of the following Raw material composition in mass percentage: Astragalus 1%, Polygonatum 0.8%, Poria cocos 1.1%, Stir-fried Atractylodes macrocephala 1%, Pueraria 1.3%, American ginseng 2.3%, Schisandra 0.8%, Digupi 2.3%, Rehmannia glutinosa 1%, Rehmannia glutinosa 1.3%, willow Bud 5%, ghost needle grass 4.5%, purslane 2%, licorice 0.4%, angelica 0.7%, ginseng 0.6%, agarwood 0.4%, persimmon leaves 6%, anemarrhena 2%, vinegar turtle 2.25%, salt cork 1.3%, Polyporus 1.35%, Gallinarum 3.3%, Desmodium 1.3%, Loofah 2.4%, Propolis 4.35%, Bitter Gourd 6.5%, Divine Comedy 2.3%, Malt 0.95%, Safflower 1.3%, Vermilion 6.5% , hawthorn 2.6%, Shouwu 2.5%, Rosa japonica 1%, Salvia miltiorrhiza 2.3%, Banzhilian 2.27%, Stevia leaves 1.51%, Corn silk 2.32%, Winter mulberry leaves 2.57%, Campanulaceae 4.1%, Polygonatum 2.3% , Chinese yam 3.63%, epimedium 0.5%, medlar 4.1%.
实施例3，本实施例提供了一种激活胰岛素调节高血糖功能的中药方及其制备、应用方法，其与实施例1基本相同，区别在于：该激活胰岛素调节高血糖功能的中药方由以下质量百分比的原料组成：黄芪0.9%、黄精0.9%、茯苓1.05%、炒白术1.1%、葛根1.5%、西洋参2.1%、五味子0.95%、地骨皮2.2%、生地1.1%、熟地1.35%、柳树芽6%、鬼针草4%、马齿苋2.2%、甘草0.2%、当归0.5%、人参1%、沉香0.2%、柿子树叶5.8%、知母2.3%、醋鳖甲2%、盐黄柏1.51%、猪苓1.3%、鸡内金3.63%、金钱草1%、丝瓜楼2.64%、蜂胶4.1%、苦瓜6.4%、神曲2%、麦芽0.7%、红花1.5%、翻白草6.4%、山楂2.5%、首乌2.3%、金樱子1.23%、丹参2%、半枝莲2.6%、甜菊叶1.3%、玉米须2.23%、冬桑叶2.5%、桔梗4.1%、玉竹2.5%、淮山3.4%、淫羊藿0.61%、枸杞子4.2%。 Embodiment 3, this embodiment provides a traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia and its preparation and application method, which is basically the same as Example 1, the difference is that the traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia consists of the following Raw material composition in mass percentage: Astragalus 0.9%, Polygonatum 0.9%, Poria cocos 1.05%, Stir-fried Atractylodes macrocephala 1.1%, Pueraria 1.5%, American ginseng 2.1%, Schisandra 0.95%, Digupi 2.2%, Rehmannia glutinosa 1.1%, Rehmannia glutinosa 1.35%, willow 6% buds, 4% ghost needle grass, 2.2% purslane, 0.2% licorice, 0.5% angelica, 1% ginseng, 0.2% agarwood, 5.8% persimmon leaves, 2.3% anemarrhena, 2% vinegar turtle, phellodendron 1.51%, Polyporus 1.3%, Gallus chinensis 3.63%, Desmodium 1%, Luffa 2.64%, Propolis 4.1%, Bitter melon 6.4%, Divine Comedy 2%, Malt 0.7%, Safflower 1.5%, Vermilion 6.4% , Hawthorn 2.5%, Shouwu 2.3%, Rosa 1.23%, Salvia miltiorrhiza 2%, Banzhilian 2.6%, Stevia leaf 1.3%, Corn silk 2.23%, Winter mulberry leaf 2.5%, Campanulaceae 4.1%, Polygonatum 2.5% , Chinese yam 3.4%, epimedium 0.61%, medlar 4.2%.
实施例4，本实施例提供了一种激活胰岛素调节高血糖功能的中药方及其制备、应用方法，其与实施例1基本相同，区别在于：该激活胰岛素调节高血糖功能的中药方由以下质量百分比的原料组成：黄芪0.95%、黄精0.88%、茯苓1%、炒白术1.08%、葛根1.45%、西洋参2%、五味子0.7%、地骨皮2%、生地0.9%、熟地1.5%、柳树芽5.8%、鬼针草4.4%、马齿苋2.1%、甘草0.3%、当归0.6%、人参0.9%、沉香0.38%、柿子树叶5.9%、知母2.2%、醋鳖甲2.2%、盐黄柏1.45%、猪苓1.4%、鸡内金3.4%、金钱草1.2%、丝瓜楼2.5%、蜂胶4.3%、苦瓜6.1%、神曲2.2%、麦芽0.88%、红花1.45%、翻白草6.1%、山楂2.45%、首乌2.52%、金樱子1.2%、丹参2.2%、半枝莲2.5%、甜菊叶1.45%、玉米须2%、冬桑叶2.55%、桔梗4.33%、玉竹2.45%、淮山3.6%、淫羊藿0.58%、枸杞子4.25%。 Embodiment 4, this embodiment provides a traditional Chinese medicine prescription for activating the function of insulin to regulate hyperglycemia and its preparation and application method, which is basically the same as that of Example 1, the difference is that the traditional Chinese medicine prescription for activating the function of insulin to regulate hyperglycemia consists of the following Raw material composition in mass percentage: Astragalus 0.95%, Polygonatum 0.88%, Poria cocos 1%, Fried Atractylodes macrocephala 1.08%, Pueraria 1.45%, American ginseng 2%, Schisandra 0.7%, Digupi 2%, Rehmannia 0.9%, Rehmannia glutinosa 1.5%, willow 5.8% buds, 4.4% ghost needles, 2.1% purslane, 0.3% licorice, 0.6% angelica, 0.9% ginseng, 0.38% agarwood, 5.9% persimmon leaves, 2.2% anemarrhena, 2.2% vinegar turtle, salt cork 1.45%, Polyporus 1.4%, Gallus chinensis 3.4%, Desmodium 1.2%, Loofah 2.5%, Propolis 4.3%, Bitter melon 6.1%, Divine Comedy 2.2%, Malt 0.88%, Safflower 1.45%, Vermilion 6.1% , hawthorn 2.45%, Shouwu 2.52%, Rosa chinensis 1.2%, Salvia miltiorrhiza 2.2%, Scutellaria barbata 2.5%, Stevia leaves 1.45%, Corn silk 2%, Winter mulberry leaves 2.55%, Campanulaceae 4.33%, Polygonatum 2.45% , Chinese yam 3.6%, epimedium 0.58%, medlar 4.25%.
实施例5，本实施例提供了一种激活胰岛素调节高血糖功能的中药方及其制备、应用方法，其与实施例1基本相同，区别在于：该激活胰岛素调节高血糖功能的中药方由以下质量百分比的原料组成：黄芪0.98%、黄精0.87%、茯苓1.08%、炒白术1.05%、葛根1.48%、西洋参2.2%、五味子0.9%、地骨皮2.25%、生地1.04%、熟地1.4%、柳树芽5.7%、鬼针草4.3%、马齿苋2.15%、甘草0.41%、当归0.55%、人参0.7%、沉香0.3%、柿子树叶5%、知母2.25%、醋鳖甲2.15%、盐黄柏1.48%、猪苓1.32%、鸡内金3.6%、金钱草1.25%、丝瓜楼2.6%、蜂胶4.2%、苦瓜6.38%、神曲2.18%、麦芽0.9%、红花1.4%、翻白草6.3%、山楂2.48%、首乌2.4%、金樱子1.18%、丹参2.18%、半枝莲2.4%、甜菊叶1.42%、玉米须2.1%、冬桑叶2.4%、桔梗4.3%、玉竹2.4%、淮山3.5%、淫羊藿0.65%、枸杞子4.22%。 Embodiment 5, this embodiment provides a traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia and its preparation and application method, which is basically the same as Example 1, the difference is that the traditional Chinese medicine prescription for activating insulin to regulate hyperglycemia consists of the following Raw material composition in mass percentage: Astragalus 0.98%, Polygonatum 0.87%, Poria cocos 1.08%, Stir-fried Atractylodes macrocephala 1.05%, Pueraria 1.48%, American ginseng 2.2%, Schisandra 0.9%, Digupi 2.25%, Rehmannia glutinosa 1.04%, Rehmannia glutinosa 1.4%, willow 5.7% buds, 4.3% ghost needle grass, 2.15% purslane, 0.41% licorice, 0.55% angelica, 0.7% ginseng, 0.3% agarwood, 5% persimmon leaves, 2.25% anemarrhena, 2.15% vinegar turtle, phellodendron 1.48%, Polyporus 1.32%, Gallinarum 3.6%, Desmodium 1.25%, Loofah 2.6%, Propolis 4.2%, Bitter Gourd 6.38%, Divine Comedy 2.18%, Malt 0.9%, Safflower 1.4%, Vermilion 6.3% , hawthorn 2.48%, Shouwu 2.4%, Rosa japonica 1.18%, Salvia miltiorrhiza 2.18%, Scutellaria barbata 2.4%, Stevia leaves 1.42%, Corn silk 2.1%, Winter mulberry leaves 2.4%, Campanulaceae 4.3%, Polygonatum 2.4% , Chinese yam 3.5%, epimedium 0.65%, medlar 4.22%.
上述实施例仅为本发明较好的实施方式，本发明不能一一列举出全部的实施方式，凡采用上述实施例之一的技术方案，或根据上述实施例所做的等同变化，均在本发明保护范围内。 The above-mentioned embodiments are only preferred implementation modes of the present invention, and the present invention cannot enumerate all the implementation modes one by one. All technical solutions using one of the above-mentioned embodiments, or equivalent changes made according to the above-mentioned embodiments, are included in this document. within the scope of invention protection.
具体的，本发明激活胰岛素调节高血糖功能的中药方有以下优点： Specifically, the traditional Chinese medicine formula for activating insulin to regulate hyperglycemia of the present invention has the following advantages:
1、无副作用。 1. No side effects.
2、可以激活并修复受损的胰岛细胞，使其产生足量的胰岛素供给糖的代谢；以胰岛再生疗法，重组基因，修复胰岛、免疫养护，三重功效，彻底告别糖尿病及并发症威胁。 2. It can activate and repair damaged islet cells so that they can produce enough insulin to supply sugar for metabolism; with islet regeneration therapy, recombinant genes, repairing islets, immune maintenance, three functions, completely bid farewell to diabetes and the threat of complications.
3、平稳的降低血糖，保持糖代谢平衡，向β细胞中受损的基因导入中药，对断裂和损坏的基因链进行桥接修复，使B细胞恢复原有的活性与分裂功能，迅速恢复细胞活性，使胰岛恢复正常，血糖永不反弹，真正达到“自愈”的效果。4、滋养并调节五脏平衡，恢复人体正常的组织代谢功能，保证身体足够的能量和营养。5、消除并发症，在修复胰腺平稳降糖的同时要想使血糖不反弹，就要阻断糖尿病的隐患及病源，消除并发症的潜在因素。固本降糖丸，依据中医学理论和现代科研理论，结合五脏和并发症的关系，首先恢复胰岛功能，同时滋养并增强五脏运化能力，进而达到有效纠正人体免疫紊乱、逆转并发症的目的。这种以养为治，在平稳血糖的基础上调五脏，从根本上康复糖尿病的双向整体疗法为糖尿病医学首创在胰岛周围形成双向作用隔离层，对胰岛内部进行全面滋养，对外防止毒素物质破坏胰岛，同时全身受损器官进行基因修复，使心脑肝肾等脏腑器官得到良好养护，机体微循环明显改善，从此远离并发症的威胁。 3. Lower blood sugar steadily, maintain the balance of glucose metabolism, introduce traditional Chinese medicine into the damaged genes in β cells, bridge and repair the broken and damaged gene chains, restore the original activity and division function of B cells, and quickly restore cell activity , so that the islets return to normal, the blood sugar never rebounds, and truly achieve the effect of "self-healing". 4. Nourish and regulate the balance of the five internal organs, restore the normal tissue metabolism function of the human body, and ensure sufficient energy and nutrition for the body. 5. Eliminate complications. If you want to prevent blood sugar from rebounding while repairing the pancreas to stabilize blood sugar, you must block the hidden dangers and causes of diabetes and eliminate the potential factors of complications. Guben Jiangtang Pills, based on the theory of traditional Chinese medicine and modern scientific research, combined with the relationship between the five internal organs and complications, first restores the function of the islets, and at the same time nourishes and enhances the transportation and transformation of the five internal organs, and then achieves the purpose of effectively correcting the immune disorder of the human body and reversing complications . This two-way holistic therapy based on nourishment, regulating the five internal organs on the basis of stabilizing blood sugar, and fundamentally recovering diabetes is the first in diabetes medicine to form a two-way isolation layer around the islets to fully nourish the inside of the islets and prevent toxins from damaging the islets. At the same time, the damaged organs of the whole body are genetically repaired, so that the organs such as the heart, brain, liver, and kidney are well maintained, the microcirculation of the body is significantly improved, and the threat of complications is far away.
根据上述说明书的揭示和教导，本发明所属领域的技术人员还可以对上述实施方式进行变更和修改。因此，本发明并不局限于上面揭示和描述的具体实施方式，对本发明的一些修改和变更也应当落入本发明的权利要求的保护范围内。此外，尽管本说明书中使用了一些特定的术语，但这些术语只是为了方便说明，并不对本发明构成任何限制，采用与其相同或相似方法及组分而得到的其它药方及其制备、应用方法，均在本发明保护范围内。 According to the disclosure and teaching of the above-mentioned specification, those skilled in the art to which the present invention belongs can also make changes and modifications to the above-mentioned embodiment. Therefore, the present invention is not limited to the specific embodiments disclosed and described above, and some modifications and changes to the present invention should also fall within the protection scope of the claims of the present invention. In addition, although some specific terms are used in this description, these terms are only for convenience of description and do not constitute any limitation to the present invention. Other prescriptions and their preparation and application methods obtained by using the same or similar methods and components, All within the protection scope of the present invention.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510433172.2A CN105031415A (en) | 2015-07-22 | 2015-07-22 | Traditional Chinese medicine formula for activating insulin to regulate hyperglycemia and its preparation and application method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510433172.2A CN105031415A (en) | 2015-07-22 | 2015-07-22 | Traditional Chinese medicine formula for activating insulin to regulate hyperglycemia and its preparation and application method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105031415A true CN105031415A (en) | 2015-11-11 |
Family
ID=54438774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510433172.2A Pending CN105031415A (en) | 2015-07-22 | 2015-07-22 | Traditional Chinese medicine formula for activating insulin to regulate hyperglycemia and its preparation and application method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105031415A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177597A (en) * | 2016-08-31 | 2016-12-07 | 洪雅县瓦屋山药业有限公司 | A kind of manufacture method of the refined even oral liquid being of value to treating diabetes |
| CN106266549A (en) * | 2016-09-29 | 2017-01-04 | 农宏珠 | A kind of pure Chinese herbal and crude drugs preparations effecting a radical cure diabetes and preparation method thereof |
| CN106511840A (en) * | 2016-11-15 | 2017-03-22 | 深圳市国民大健康文化传播有限公司 | Composition for consolidating and reducing blood glucose, and preparation method thereof |
| CN106853229A (en) * | 2015-12-08 | 2017-06-16 | 天津天中医药科技有限公司 | Chinese medicinal formulae of prevention and treatment diabetes and diabetic complications and preparation method thereof |
| CN107412624A (en) * | 2017-08-25 | 2017-12-01 | 宁夏伊康回族医药研究所（有限公司） | One kind return medicine hypoglycemic disappear fat spirit |
| CN107853652A (en) * | 2017-10-30 | 2018-03-30 | 东莞珍其道健康食品科技有限公司 | Hypoglycemic is depressured health-care soup base |
| CN110772630A (en) * | 2019-10-25 | 2020-02-11 | 运鸿集团股份有限公司 | Compound bitter melon peptide oral liquid for activating insulin receptor and regulating blood sugar and preparation method |
| CN112843190A (en) * | 2019-11-27 | 2021-05-28 | 祁东县柯佳特色医术研究所 | Blood sugar reducing pill and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1224614A (en) * | 1998-01-24 | 1999-08-04 | 倪德贵 | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation |
| CN102266520A (en) * | 2011-07-25 | 2011-12-07 | 王保江 | Traditional Chinese medicine composition for treating diabetes |
| CN102274447A (en) * | 2011-08-27 | 2011-12-14 | 赵国辉 | Medicinal composition for treating diabetes |
| CN102861263A (en) * | 2012-09-24 | 2013-01-09 | 天津鑫瑞生物医药科技有限公司 | Blood glucose reducing preparation made of pure traditional Chinese medicines |
-
2015
- 2015-07-22 CN CN201510433172.2A patent/CN105031415A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1224614A (en) * | 1998-01-24 | 1999-08-04 | 倪德贵 | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation |
| CN102266520A (en) * | 2011-07-25 | 2011-12-07 | 王保江 | Traditional Chinese medicine composition for treating diabetes |
| CN102274447A (en) * | 2011-08-27 | 2011-12-14 | 赵国辉 | Medicinal composition for treating diabetes |
| CN102861263A (en) * | 2012-09-24 | 2013-01-09 | 天津鑫瑞生物医药科技有限公司 | Blood glucose reducing preparation made of pure traditional Chinese medicines |
Non-Patent Citations (2)
| Title |
|---|
| 中医夜话: "中草药【固本降糖丸】代替胰岛素", 《HTTP://BLOG.SINA.COM.CN/S/BLOG_516174280102UYBQ.HTML》 * |
| 洪文旭: "降糖类的药理作用", 《HTTP://BLOG.SINA.COM.CN/S/BLOG_4FC7197D01010BNR.HTML》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106853229A (en) * | 2015-12-08 | 2017-06-16 | 天津天中医药科技有限公司 | Chinese medicinal formulae of prevention and treatment diabetes and diabetic complications and preparation method thereof |
| CN106177597A (en) * | 2016-08-31 | 2016-12-07 | 洪雅县瓦屋山药业有限公司 | A kind of manufacture method of the refined even oral liquid being of value to treating diabetes |
| CN106266549A (en) * | 2016-09-29 | 2017-01-04 | 农宏珠 | A kind of pure Chinese herbal and crude drugs preparations effecting a radical cure diabetes and preparation method thereof |
| CN106511840A (en) * | 2016-11-15 | 2017-03-22 | 深圳市国民大健康文化传播有限公司 | Composition for consolidating and reducing blood glucose, and preparation method thereof |
| CN107412624A (en) * | 2017-08-25 | 2017-12-01 | 宁夏伊康回族医药研究所（有限公司） | One kind return medicine hypoglycemic disappear fat spirit |
| CN107853652A (en) * | 2017-10-30 | 2018-03-30 | 东莞珍其道健康食品科技有限公司 | Hypoglycemic is depressured health-care soup base |
| CN110772630A (en) * | 2019-10-25 | 2020-02-11 | 运鸿集团股份有限公司 | Compound bitter melon peptide oral liquid for activating insulin receptor and regulating blood sugar and preparation method |
| CN112843190A (en) * | 2019-11-27 | 2021-05-28 | 祁东县柯佳特色医术研究所 | Blood sugar reducing pill and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105031415A (en) | Traditional Chinese medicine formula for activating insulin to regulate hyperglycemia and its preparation and application method | |
| CN102139084B (en) | A traditional Chinese medicine composition for treating fatty liver and its preparation method and application | |
| CN104288501A (en) | Blood glucose reducing particle and preparation method thereof | |
| CN103740566A (en) | Rosa roxbunghii medicinal liquor and preparation method thereof | |
| CN101543248B (en) | A cold tea especially suitable for 'three high and one acid' population and method for preparing same | |
| CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
| CN106912943A (en) | The medicine or health food of a kind of strengthen immunity | |
| CN102973779A (en) | Traditional Chinese medicine composition for treating seborrheic dermatitis and acne and preparation method thereof | |
| CN101099844A (en) | Compound for spleen-strengthening and kidney-nourishing preparation and preparing method | |
| CN104815166B (en) | A kind of Chinese medicine composition for treating diabetes and its preparation and application | |
| CN108310298A (en) | It is a kind of that there is the Chinese medicine composition and preparation method for alleviating asthenopia, prevention myopia | |
| CN118217359A (en) | A Chinese medicine composition for treating type 2 diabetes with qi and yin deficiency syndrome | |
| CN106176909A (en) | A kind of method that Radix Ginseng Rhizoma Atractylodis Macrocephalae Poria Radix Glycyrrhizae prepares four gentleman's enzyme beverage | |
| CN102552631A (en) | Chinese herbal preparation having protective effect on alcoholic hepatic injury | |
| CN105267559A (en) | Diabetic peripheral neuropathy treatment medicine and manufacturing method thereof | |
| CN103989996A (en) | Traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN104645015A (en) | Traditional Chinese medicine compound preparation for treating vascular dementia and preparation method of traditional Chinese medicine compound preparation | |
| CN103070909B (en) | Three stilbene soft capsules and preparation method thereof | |
| CN113018398A (en) | Anti-fatigue health product and preparation method thereof | |
| CN113826882A (en) | Dietary nutrition supplement for preventing and treating diabetes and preparation process thereof | |
| CN105250588A (en) | Traditional Chinese medicine preparation for treating renal failure and preparation method thereof | |
| CN105796755A (en) | Traditional Chinese medicinal composition for treating diabetic nephropathy | |
| CN111956736A (en) | Hypoglycemic composition mainly comprising sparassis crispa as well as preparation method and application thereof | |
| WO2015018123A1 (en) | Traditional chinese medicine preparation for reducing blood sugar and preparation method thereof | |
| CN108392583A (en) | A kind of Chinese medicine preparation for treating diabetic nephropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151111 |
|
| RJ01 | Rejection of invention patent application after publication |